Skip to main content
OpenTrials
Completed

NCT Number: NCT04444232

Cancer Communication Within Hispanic Social Networks

This trial examines cancer communication within Hispanic social networks. Hispanics have the lowest colorectal cancer screening rate of any major ethnic group and health interventions are crucially needed among Hispanics. Patient decision aids are health communication interventions designed to provide patients with targeted health information and have shown to improve colorectal cancer screening rates among Hispanics. The goal of this study is to investigate, in a sample of Hispanics, how a colorectal cancer decision aid aimed at increasing individuals' colorectal cancer screening behavior has effects on their alters' intention to get screened for colorectal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Carcinoma Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

50 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

About this study

OUTLINE:

Participants view an educational video on cancer and cancer screening options over 12 minutes. Participants also complete a phone survey over 10-15 minutes before attending the video session and 2 months after the video session.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-identify as "Hispanic" or "Latino"
  • Have no family history of CRC
  • Have no personal history of pre-cancerous (adenomatous) colonic polyps
  • Have not had either an annual fecal occult blood test (FOBT) within the past year or colonoscopy within the last 10 years (defined as up-to-date with CRC screening by current United States [U.S.] Preventive Services Task Force recommendations)
  • Have at least two family members, friends, or co-workers who are ages 50-75
  • Alters will be eligible if they are ages 50-75

Treatment and study plan

Media Intervention

Other

View an educational video

Survey Administration

Other

Complete survey

Primary outcomes

  1. Patients' communication with their families, friends, and co-workers about colorectal cancer (CRC) screening

    Time frame: Up to 6 months

    Will be assessed using a single dichotomized question with two response options ('yes' or 'no'). CRC communication constitutes in-person conversation, email, phone, or post on social media (e.g., blog, Twitter, Facebook). Will also assess the characteristics of the alters by asking the patients two questions on social-tie dimensions: 1) contact frequency (never, rarely, sometimes, often, or very often) and 2) personal relationship (acquaintance , close friend , co-worker, relatives, or spouse).

  2. Alters' intent to become screened for CRC in the next six months

    Time frame: Up to 6 months

    Intent will be assessed using a single categorical item with three response options (definitely planning to be screened, considering being screened, not considering being screened).

Sponsors and collaborators

Lead sponsor

Fred Hutchinson Cancer Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Cancer Communication Within Social Networks

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jun 23, 2020
Registry last updated
Jun 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.